FATE THERAPEUTICS INC
Industry: Biotechnology (See others in industry)
Address:
3535 General Atomics Court Suite 200
San Diego, CA, 92121
Phone: 858.875.1800
San Diego, CA, 92121
Phone: 858.875.1800
Filings
| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2020-07-06 | New | $49,999,989 | $49,999,989 | Equity Only | 06b | SEC link |
| 2020-04-21 | New | $50,000,024 | $50,000,024 | Equity Only | 06b | SEC link |
| 2016-12-08 | New | $56,749,988 | $56,749,988 | Equity Only | 06b | SEC link |
| 2016-08-19 | New | $10,290,000 | $10,290,000 | Equity Only | 06b | SEC link |
| 2015-05-18 | New | $8,000,000 | $8,000,000 | Equity Only | 06b | SEC link |
| 2013-08-13 | New | $20,000,000 | $20,000,000 | Debt Only | 06 | SEC link |
| 2012-08-21 | New | $9,244,679 | $9,244,679 | Equity Only | 06 | SEC link |
| 2011-04-20 | Amended | $35,988,360 | $3,500,000 | Equity Only | 06 | SEC link |
| 2011-04-20 | New | $1,000,000 | $1,000,000 | Debt Only | 06 | SEC link |
| 2009-12-24 | Amended | $32,488,360 | $2,000,000 | Equity Only | 06 | SEC link |
| 2009-11-23 | New | $30,488,360 | $30,488,360 | Equity Only | 06 | SEC link |
| 2008-05-02 | Paper Filing | Unknown | Unknown | Other | Not Available | |
| 2008-05-02 | Paper Filing | Unknown | Unknown | Other | Not Available |
Directors and Executives (Current and Past)
| Name | Role |
|---|---|
| Stewart Abbot | Executive |
| Shefali Agarwal | Director |
| Timothy Coughlin | Director |
| Mark J. Enyedy | Director |
| Robert Epstein | Director |
| Paul Grayson | Director, Executive |
| Robert Hershberg | Director |
| Karin Jooss | Director |
| Michael Lee | Director |
| John Mendlein | Director |
| Amir Nashat | Director |
| Robert Nelsen | Director |
| William Rastetter | Director |
| Bryan Roberts | Director |
| Daniel D. Shoemaker | Executive |
| Chris Storgard | Executive |
| Cindy Tahl | Executive |
| Carl Weissman | Director |
| Christian Weyer | Director, Executive |
| J. Scott Wolchko | Director, Executive |
| Scott Wolchko | Executive |